Search - tctmd.com

Displaying 161 - 180 of 184

Sort: Relevancy | Date

News Daily News

High-Dose Edoxaban as Effective as Warfarin for Stroke Prevention in A-fib

Yael L. Maxwell

June 27, 2014

News Daily News

ROCKET AF Substudy: Rivaroxaban Safe, Effective in East Asian Patients

L.A. McKeown

April 29, 2014

News Daily News

ROCKET AF Analysis Isolates Predictors of Intracranial Hemorrhage in A-fib Population

L.A. McKeown

April 22, 2014

News Daily News

Clinical Outcomes of Carotid Stenting Comparable in Radiation-Induced and Atherosclerotic Stenoses

L.A. McKeown

April 11, 2014

News Daily News

Los Resultados Clínicos de la Implantación de Stents Carotídeos son Parecidos en las Estenosis inducidas por Radiación y en las Ateroscleróticas

L.A. McKeown

April 11, 2014

News Conference News ACC 2014

ARISTOTLE: Blood Pressure Adversely Affects Stroke Risk in A-fib Patients

Caitlin E. Cox

April 02, 2014

News Daily News

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Caitlin E. Cox

February 26, 2014

News Daily News

Apixaban es Rentable comparado con Warfarina o Aspirina

Caitlin E. Cox

February 26, 2014

News Daily News

Troponin T Improves Clinical Stroke Risk Assessment in A-fib Patients

October 04, 2013

News Conference News ESC 2013

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

Caitlin E. Cox

September 03, 2013

News Daily News

El FOP Aumenta el Riesgo de ACV tras la Implantación de los Electrodos del Dispositivo Endovascular

August 30, 2013

News Daily News

Después de un accidente cerebrovascular menor/AIT, la terapia antiplaquetaria doble reduce el accidente cerebrovascular recurrente en comparación con la aspirina

July 24, 2013

News Daily News

After Minor Stroke/TIA, Dual Antiplatelet Therapy Reduces Recurrent Stroke vs. Aspirin

July 24, 2013

Presentation TCT 2012

Novel Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation

Presenter: Jonathan Halperin

October 25, 2012

News Daily News

La Escala de Riesgo Predice los ACV o Muerte en Candidatos a recibir un Stent de Carótida

Jason Kahn

September 28, 2012

News Daily News

Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years

Caitlin E. Cox

July 12, 2012

News Daily News

A los 10 Años el Apixaban resulta Más Barato que la Aspirina para la Prevención de ACV en Pacientes con FA

Caitlin E. Cox

July 12, 2012

Presentation

Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants (Dabigatran, Rivaroxaban, Apixaban) vs. Warfarin in Patients with A-fib

Presenter: Corey S. Miller

May 03, 2012

Presentation

New Oral Anticoagulants for Stroke Prevention

Presenter: Nicole R. Gonzales

May 02, 2012

News Daily News

Paper Examines Differences Between Observational, Randomized PFO Closure Studies

L.A. McKeown

March 06, 2012

Advertisement

High-Dose Edoxaban as Effective as Warfarin for Stroke Prevention in A-fib

ROCKET AF Substudy: Rivaroxaban Safe, Effective in East Asian Patients

ROCKET AF Analysis Isolates Predictors of Intracranial Hemorrhage in A-fib Population

Clinical Outcomes of Carotid Stenting Comparable in Radiation-Induced and Atherosclerotic Stenoses

Los Resultados Clínicos de la Implantación de Stents Carotídeos son Parecidos en las Estenosis inducidas por Radiación y en las Ateroscleróticas

ARISTOTLE: Blood Pressure Adversely Affects Stroke Risk in A-fib Patients

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Apixaban es Rentable comparado con Warfarina o Aspirina

Troponin T Improves Clinical Stroke Risk Assessment in A-fib Patients

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

El FOP Aumenta el Riesgo de ACV tras la Implantación de los Electrodos del Dispositivo Endovascular

Después de un accidente cerebrovascular menor/AIT, la terapia antiplaquetaria doble reduce el accidente cerebrovascular recurrente en comparación con la aspirina

After Minor Stroke/TIA, Dual Antiplatelet Therapy Reduces Recurrent Stroke vs. Aspirin

Novel Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation

La Escala de Riesgo Predice los ACV o Muerte en Candidatos a recibir un Stent de Carótida

Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years

A los 10 Años el Apixaban resulta Más Barato que la Aspirina para la Prevención de ACV en Pacientes con FA

Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants (Dabigatran, Rivaroxaban, Apixaban) vs. Warfarin in Patients with A-fib

New Oral Anticoagulants for Stroke Prevention

Paper Examines Differences Between Observational, Randomized PFO Closure Studies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content